NBMPR

CAS No. 38048-32-7

NBMPR( —— )

Catalog No. M22189 CAS No. 38048-32-7

Nitrobenzylthioinosine is an inhibitor of ENT1 transporter that binds to ENT1 transporter with high affinity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 42 In Stock
5MG 29 In Stock
10MG 38 In Stock
25MG 77 In Stock
50MG 126 In Stock
100MG 206 In Stock
200MG 305 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NBMPR
  • Note
    Research use only, not for human use.
  • Brief Description
    Nitrobenzylthioinosine is an inhibitor of ENT1 transporter that binds to ENT1 transporter with high affinity.
  • Description
    Nitrobenzylthioinosine is an inhibitor of ENT1 transporter that binds to ENT1 transporter with high affinity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ENT
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    38048-32-7
  • Formula Weight
    419.4
  • Molecular Formula
    C17H17N5O6S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (119.22 mM)
  • SMILES
    OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1cnc2c(SCc3ccc(cc3)[N+]([O-])=O)ncnc12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. P J Marangos, et al. [3H]nitrobenzylthioinosine is a photoaffinity probe for adenosine uptake sites in brain. Eur J Pharmacol. 1982 Dec 3;85(3-4):359-60.
molnova catalog
related products
  • Carcinoembryonic Ant...

    Carcinoembryonic antigen (CEA) is a protein that is present in certain tissues of a developing baby (fetus)

  • Oxybenzone

    Oxybenzone is an organic compound used in sunscreens. It is a derivative of benzophenone.

  • Dimethylaminomicheli...

    Dimethylaminomicheliolide HCl has potential anti-inflammatory and anti-tumor activity and inhibits the proliferation of glioblastoma cells by targeting pyruvate kinase 2 (PKM2) and reconnecting aerobic cell populations.